# Magyar Bancorp, Inc.: financial statements, quarterly

MGYR · Nasdaq · CIK 1337068 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/mgyr.md) · [Financials](/companies/mgyr/financials.md) · [Filings](/companies/mgyr/filings.md) · [Insiders](/companies/mgyr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgyr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [3,608 d](/filings/0001174947-23-001465.md) | [4,313](/filings/0001174947-24-000217.md) | [4,997](/filings/0001174947-24-000737.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [674 d](/filings/0001174947-24-001365.md) | [700](/filings/0001174947-25-000166.md) | [526](/filings/0001174947-25-000760.md) | [501](/filings/0001174947-25-001154.md) | [1,591 d](/filings/0002077096-25-000193.md) | [805](/filings/0001174947-26-000170.md) | [1,095](/filings/0001174947-26-000591.md) | [1,004](/filings/0001174947-26-000796.md) | [1,145 d](/filings/0002077096-25-000193.md) | [1,141](/filings/0001174947-26-000170.md) | [1,238](/filings/0001174947-26-000591.md) | [1,260](/filings/0001174947-26-000796.md) |
| Net income | $k | [2,185 d](/filings/0001174947-24-001365.md) | [1,652](/filings/0001174947-25-001154.md) | [1,897](/filings/0001174947-25-001154.md) | [1,691](/filings/0001174947-25-001154.md) | [2,543 d](/filings/0002077096-25-000193.md) | [2,085](/filings/0001174947-26-000796.md) | [2,681](/filings/0001174947-26-000796.md) | [2,470](/filings/0001174947-26-000796.md) | [2,525 d](/filings/0002077096-25-000193.md) | [3,136](/filings/0001174947-26-000796.md) | [3,030](/filings/0001174947-26-000796.md) | [3,093](/filings/0001174947-26-000796.md) |
| Diluted EPS | $ per share | not reported | [0.26](/filings/0001174947-25-000166.md) | [0.30](/filings/0001174947-25-000760.md) | [0.27](/filings/0001174947-25-001154.md) | not reported | [0.33](/filings/0001174947-26-000170.md) | [0.43](/filings/0001174947-26-000591.md) | [0.40](/filings/0001174947-26-000796.md) | not reported | [0.50](/filings/0001174947-26-000170.md) | [0.48](/filings/0001174947-26-000591.md) | [0.49](/filings/0001174947-26-000796.md) |
| Basic EPS | $ per share | not reported | [0.26](/filings/0001174947-25-000166.md) | [0.30](/filings/0001174947-25-000760.md) | [0.27](/filings/0001174947-25-001154.md) | not reported | [0.34](/filings/0001174947-26-000170.md) | [0.43](/filings/0001174947-26-000591.md) | [0.40](/filings/0001174947-26-000796.md) | not reported | [0.51](/filings/0001174947-26-000170.md) | [0.49](/filings/0001174947-26-000591.md) | [0.50](/filings/0001174947-26-000796.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [72.5](/filings/0001174947-24-001365.md) | [51.1](/filings/0001174947-24-000217.md) | [50.0](/filings/0001174947-24-000737.md) | [49.0](/filings/0001174947-24-001002.md) | [25.6](/filings/0002077096-25-000193.md) | [58.5](/filings/0001174947-25-000166.md) | [72.9](/filings/0001174947-25-000760.md) | [7.1](/filings/0001174947-25-001154.md) | [7.1](/filings/0001174947-26-000796.md) | [34.1](/filings/0001174947-26-000170.md) | [47.6](/filings/0001174947-26-000591.md) | [11.5](/filings/0001174947-26-000796.md) |
| Total assets | $m | [907](/filings/0001174947-24-001365.md) | [917](/filings/0001174947-24-000217.md) | [929](/filings/0001174947-24-000737.md) | [944](/filings/0001174947-24-001002.md) | [952](/filings/0002077096-25-000193.md) | [1,008](/filings/0001174947-25-000166.md) | [1,022](/filings/0001174947-25-000760.md) | [987](/filings/0001174947-25-001154.md) | [998](/filings/0001174947-26-000796.md) | [1,045](/filings/0001174947-26-000170.md) | [1,068](/filings/0001174947-26-000591.md) | [1,049](/filings/0001174947-26-000796.md) |
| Total liabilities | $m | [803](/filings/0001174947-24-001365.md) | [810](/filings/0001174947-24-000217.md) | [821](/filings/0001174947-24-000737.md) | [835](/filings/0001174947-24-001002.md) | [841](/filings/0002077096-25-000193.md) | [897](/filings/0001174947-25-000166.md) | [908](/filings/0001174947-25-000760.md) | [871](/filings/0001174947-25-001154.md) | [879](/filings/0001174947-26-000796.md) | [924](/filings/0001174947-26-000170.md) | [944](/filings/0001174947-26-000591.md) | [922](/filings/0001174947-26-000796.md) |
| Long-term debt | $m | [29.5](/filings/0001174947-24-001365.md) | not reported | not reported | not reported | [28.6](/filings/0002077096-25-000193.md) | [30.4](/filings/0001174947-25-000166.md) | [33.9](/filings/0001174947-25-000760.md) | [36.1](/filings/0001174947-25-001154.md) | [49.1](/filings/0001174947-26-000796.md) | [49.1](/filings/0001174947-26-000170.md) | [49.1](/filings/0001174947-26-000591.md) | [49.1](/filings/0001174947-26-000796.md) |
| Current portion of debt | $m | [29.5](/filings/0001174947-24-001002.md) | [28.8](/filings/0001174947-24-000217.md) | [28.8](/filings/0001174947-24-000737.md) | [28.6](/filings/0001174947-24-001002.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [105](/filings/0002077096-25-000193.md) | [107](/filings/0001174947-25-001154.md) | [108](/filings/0001174947-25-001154.md) | [109](/filings/0001174947-25-001154.md) | [111](/filings/0001174947-26-000796.md) | [112](/filings/0001174947-26-000796.md) | [114](/filings/0001174947-26-000796.md) | [116](/filings/0001174947-26-000796.md) | [119](/filings/0001174947-26-000796.md) | [122](/filings/0001174947-26-000796.md) | [124](/filings/0001174947-26-000796.md) | [127](/filings/0001174947-26-000796.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,931 d](/filings/0001174947-24-001365.md) | [3,224](/filings/0001174947-25-000166.md) | [553 d](/filings/0001174947-25-000760.md) | [1,686 d](/filings/0001174947-25-001154.md) | [855 d](/filings/0002077096-25-000193.md) | [2,908](/filings/0001174947-26-000170.md) | [2,380 d](/filings/0001174947-26-000591.md) | [2,255 d](/filings/0001174947-26-000796.md) | [2,846 d](/filings/0002077096-25-000193.md) | [3,675](/filings/0001174947-26-000170.md) | [3,232 d](/filings/0001174947-26-000591.md) | [5,223 d](/filings/0001174947-26-000796.md) |
| Capital expenditure | $k | not reported | [128](/filings/0001174947-25-000166.md) | [125 d](/filings/0001174947-25-000760.md) | [141 d](/filings/0001174947-25-001154.md) | [418 d](/filings/0002077096-25-000193.md) | [375](/filings/0001174947-26-000170.md) | [102 d](/filings/0001174947-26-000591.md) | [45.0 d](/filings/0001174947-26-000796.md) | [52.0 d](/filings/0002077096-25-000193.md) | [4.0](/filings/0001174947-26-000170.md) | [329 d](/filings/0001174947-26-000591.md) | [462 d](/filings/0001174947-26-000796.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | [318 d](/filings/0002077096-25-000193.md) | not reported | not reported | not reported | [501 d](/filings/0002077096-25-000193.md) | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,459](/filings/0001174947-24-000217.md) | [6,432](/filings/0001174947-24-000737.md) | [6,413](/filings/0001174947-24-001002.md) | [6,387](/filings/0001174947-25-000166.md) | [6,372](/filings/0001174947-25-000760.md) | [6,337](/filings/0001174947-25-001154.md) | [6,236](/filings/0001174947-26-000170.md) | [6,225](/filings/0001174947-26-000591.md) | [6,232](/filings/0001174947-26-000796.md) | [6,276](/filings/0001174947-26-000170.md) | [6,294](/filings/0001174947-26-000591.md) | [6,288](/filings/0001174947-26-000796.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,455,383 at 2026-08-01, from the cover of the [10-Q filed 2026-08-13](/filings/0001174947-26-000796.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.